Amarex Clinical Research
Private Company
Funding information not available
Overview
Amarex Clinical Research is an established, privately-held CRO with over two decades of experience managing clinical trials and regulatory submissions. The company offers end-to-end services including project management, regulatory affairs, data management, biostatistics, clinical operations, medical writing, and pharmacovigilance, boasting a track record of over 400 studies in more than 35 countries. Its business model is purely service-based, generating revenue by partnering with biopharma and medtech sponsors to develop their products, rather than developing its own therapeutic assets. Amarex positions itself as a specialized partner with deep expertise in complex regulatory strategies and real-time, compliant data management systems.
Technology Platform
100% web-based, 21 CFR Part 11 compliant electronic data capture (EDC) and data management system, validated by FDA audits, enabling real-time data access and management for sponsors and sites.
Opportunities
Risk Factors
Competitive Landscape
Amarex competes in the fragmented global CRO market against large, full-service players like IQVIA, ICON, and Labcorp, as well as many small to mid-sized specialized CROs. Its differentiation is based on a consultative partnership model, deep regulatory expertise (particularly for HCT/Ps), and a compliant real-time data management system, rather than scale alone.